The typical patient has obvious signs of advanced nutritional cirrhosis.
典型的病人有明显的晚期营养性肝硬变的体症.
It has a higher incidence in postnecrotic cirrhosis and hemochromatosis than in Laennec's cirrhosis.
坏死后肝硬变及血色素沉着症引起的肝癌比门脉性肝硬变所引起者为多.
Objective : To analyze clinical effect of Fengshi decoction liver cirrhotic ascites.
目的: 观察蜂实饮治疗肝硬变腹水的疗效.
The liver cirrhosis model was established in Wistar rats with CCl _ 4 injection.
本文采用60%四氯化碳(CCl4)皮下注射复制大鼠肝硬变模型.
Objective To understand the treatment of alcoholic cirrhosis.
目的了解酒精性肝硬变的治疗与转归.
Correlation between syndrome differentiation and serum apolipoprotein levels in patients with liver cirrhosis.
肝硬变中医辨证分型与血清载脂蛋白变化的关系.
The advanced patients often possess severe jaundice, severe liver dysfunction, biliary cirrhosis, portal hypertension.
晚期病人常有重度黄疸 、 严重肝功能损害 、 胆汁性肝硬变 、 门静脉高压症的表现.
Objective To evaluate the portal hemodynamic changes with hepatic cirrhosis and hypertension treated with PSE.
目的评价肝硬变病人行部分脾栓塞术(PSE) 前后门脉血流动力学变化.
The effect of the proliferation of intrahepatic elastic fibers on hepatic fibrosis ( Fi ) and cirrhosis ( Ci ) was not clear.
肝内弹力纤维增生在肝纤维化 ( Fi ) 和肝硬变 ( Ci ) 中的作用尚不清楚.
The Clinical Observation of Cirrhotic Portal Hypertension TIPSS Treated and TIPSS with SEEV ( Analysis of 84 caes )
TIPSS与TIPSS并用SEEV治疗肝硬变门静脉高压的临床观察 ( 附84例报告 )
About patient of ascites of cirrhosis of the liver total caloric is calculated.
关于肝硬变腹水患者总热量的计算.
Seventeen ( 77.3 % ) patients were associated with liver cirrhosis, nineteen ( 86.4 % ) patients had positive AFP by counter - immunoelectrophoretic method.
17例 ( 77.3% ) 合并有肝硬变, 19例 ( 86.4% ) 的甲胎蛋白对流法为阳性.
Conclusion NO plays an important role in hyperdynamic circulation in cirrhotic portal hypertension.
结论肝硬变门脉高压中NO过量形成在高动力循环中起重要作用.